Journal of Ethnopharmacology, ISSN 0378-8741, 2009, Volume 121, Issue 3, pp. 433 - 443
The effects and plausible mechanism of action of Roxb. (Zingiberaceae) rhizome chloroform and methanol extracts on the uterine contraction were investigated...
Relaxation | Extract | Rat | Uterus | Rhizome | Curcuma aeruginosa | PROSTAGLANDIN-F2-ALPHA | CHEMISTRY, MEDICINAL | CONTRACTILITY | ESSENTIAL OIL | MECHANISMS | ANTAGONISM | MYOMETRIUM | PLANT SCIENCES | SMOOTH-MUSCLE | INTEGRATIVE & COMPLEMENTARY MEDICINE | CALCIUM | DRUGS | OXYTOCIN | PHARMACOLOGY & PHARMACY | Oxytocics - pharmacology | Diclofenac - pharmacology | Oxytocin - pharmacology | Vasodilator Agents - pharmacology | Rats, Wistar | Acetylcholine - pharmacology | Plant Extracts - pharmacology | Uterus - drug effects | Rats | Atropine - pharmacology | Calcium Channel Blockers - pharmacology | Parasympatholytics - pharmacology | Verapamil - pharmacology | Uterine Contraction - drug effects | Propranolol - pharmacology | Animals | Isoproterenol - pharmacology | Female | Curcuma | Dinoprost - pharmacology
Relaxation | Extract | Rat | Uterus | Rhizome | Curcuma aeruginosa | PROSTAGLANDIN-F2-ALPHA | CHEMISTRY, MEDICINAL | CONTRACTILITY | ESSENTIAL OIL | MECHANISMS | ANTAGONISM | MYOMETRIUM | PLANT SCIENCES | SMOOTH-MUSCLE | INTEGRATIVE & COMPLEMENTARY MEDICINE | CALCIUM | DRUGS | OXYTOCIN | PHARMACOLOGY & PHARMACY | Oxytocics - pharmacology | Diclofenac - pharmacology | Oxytocin - pharmacology | Vasodilator Agents - pharmacology | Rats, Wistar | Acetylcholine - pharmacology | Plant Extracts - pharmacology | Uterus - drug effects | Rats | Atropine - pharmacology | Calcium Channel Blockers - pharmacology | Parasympatholytics - pharmacology | Verapamil - pharmacology | Uterine Contraction - drug effects | Propranolol - pharmacology | Animals | Isoproterenol - pharmacology | Female | Curcuma | Dinoprost - pharmacology
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 2010, Volume 641, Issue 2, pp. 207 - 212
Adipose tissue releases an “adipocyte-derived relaxing factor” (ADRF) lowering tone of isolated arteries. The potential influence of hypoxia on the...
Relaxation | Hypoxia | Adipose tissue | Arteries | ADIPOCYTES | ADENOSINE | HYDROGEN-SULFIDE | INFLAMMATION | DYSREGULATION | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | VASODILATION | ARTERIAL TONE | EXPRESSION | Norepinephrine - pharmacology | Tetraethylammonium - pharmacology | Theophylline - analogs & derivatives | Cell Hypoxia - physiology | Prostaglandins - pharmacology | Male | Soluble Guanylyl Cyclase | Arteries - drug effects | Adenosine - pharmacology | Receptors, Cytoplasmic and Nuclear - pharmacology | Potassium - pharmacology | Adipose Tissue - metabolism | Animals | Guanylate Cyclase - pharmacology | Glyburide - pharmacology | Aorta, Thoracic - physiology | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid - pharmacology | Theophylline - pharmacology | Mice | Aorta, Thoracic - drug effects | Vasodilation - physiology | Dinoprost - pharmacology | Sulfides - pharmacology | Adipose tissues | Lactates | Glibenclamide | Theophylline
Relaxation | Hypoxia | Adipose tissue | Arteries | ADIPOCYTES | ADENOSINE | HYDROGEN-SULFIDE | INFLAMMATION | DYSREGULATION | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | VASODILATION | ARTERIAL TONE | EXPRESSION | Norepinephrine - pharmacology | Tetraethylammonium - pharmacology | Theophylline - analogs & derivatives | Cell Hypoxia - physiology | Prostaglandins - pharmacology | Male | Soluble Guanylyl Cyclase | Arteries - drug effects | Adenosine - pharmacology | Receptors, Cytoplasmic and Nuclear - pharmacology | Potassium - pharmacology | Adipose Tissue - metabolism | Animals | Guanylate Cyclase - pharmacology | Glyburide - pharmacology | Aorta, Thoracic - physiology | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid - pharmacology | Theophylline - pharmacology | Mice | Aorta, Thoracic - drug effects | Vasodilation - physiology | Dinoprost - pharmacology | Sulfides - pharmacology | Adipose tissues | Lactates | Glibenclamide | Theophylline
Journal Article
Acta Pharmacologica Sinica, ISSN 1671-4083, 12/2008, Volume 29, Issue 12, pp. 1419 - 1424
Aim: Endothelium-dependent relaxations to certain neurohumoral substances are mediated by pertussis toxin-sensitive Gi/o protein. Our experiments were designed...
CELLS | DEPENDENT RELAXATION | ANANDAMIDE | MESENTERIC-ARTERY | NATRIURETIC PEPTIDE | CHEMISTRY, MULTIDISCIPLINARY | endothelium-derived hyperpolarizing factor | Gi/o protein | pig coronary artery | L-ARGININE | pertussis toxin | PHARMACOLOGY & PHARMACY | RECEPTORS | EXPRESSION | EDHF | Endothelium-Dependent Relaxing Factors - pharmacology | Hemostatics - pharmacology | Peptide Fragments - pharmacology | Substance P - pharmacology | Apamin - pharmacology | Serotonin - pharmacology | Dose-Response Relationship, Drug | Thrombin - pharmacology | Charybdotoxin - pharmacology | Neurotransmitter Agents - pharmacology | Dinoprost - pharmacology | Bradykinin - pharmacology | Ionophores - pharmacology | Pertussis Toxin - pharmacology | NG-Nitroarginine Methyl Ester - pharmacology | Ketanserin - pharmacology | Coronary Vessels - drug effects | Vasodilator Agents - pharmacology | Coronary Vessels - physiology | Enzyme Inhibitors - pharmacology | Serotonin Antagonists - pharmacology | Calcimycin - pharmacology | Neurotoxins - pharmacology | Animals | Muscle Relaxation - drug effects | GTP-Binding Protein alpha Subunits, Gi-Go - metabolism | Sus scrofa | Biological Factors - pharmacology | Tocolytic agents | Swine | Tachykinins | Bradykinin | Thrombin | Indomethacin | Carbonates | Endothelium-derived relaxing factors | Peptide hormones | Arteries | Endothelium | Index Medicus
CELLS | DEPENDENT RELAXATION | ANANDAMIDE | MESENTERIC-ARTERY | NATRIURETIC PEPTIDE | CHEMISTRY, MULTIDISCIPLINARY | endothelium-derived hyperpolarizing factor | Gi/o protein | pig coronary artery | L-ARGININE | pertussis toxin | PHARMACOLOGY & PHARMACY | RECEPTORS | EXPRESSION | EDHF | Endothelium-Dependent Relaxing Factors - pharmacology | Hemostatics - pharmacology | Peptide Fragments - pharmacology | Substance P - pharmacology | Apamin - pharmacology | Serotonin - pharmacology | Dose-Response Relationship, Drug | Thrombin - pharmacology | Charybdotoxin - pharmacology | Neurotransmitter Agents - pharmacology | Dinoprost - pharmacology | Bradykinin - pharmacology | Ionophores - pharmacology | Pertussis Toxin - pharmacology | NG-Nitroarginine Methyl Ester - pharmacology | Ketanserin - pharmacology | Coronary Vessels - drug effects | Vasodilator Agents - pharmacology | Coronary Vessels - physiology | Enzyme Inhibitors - pharmacology | Serotonin Antagonists - pharmacology | Calcimycin - pharmacology | Neurotoxins - pharmacology | Animals | Muscle Relaxation - drug effects | GTP-Binding Protein alpha Subunits, Gi-Go - metabolism | Sus scrofa | Biological Factors - pharmacology | Tocolytic agents | Swine | Tachykinins | Bradykinin | Thrombin | Indomethacin | Carbonates | Endothelium-derived relaxing factors | Peptide hormones | Arteries | Endothelium | Index Medicus
Journal Article
Antioxidants & Redox Signaling, ISSN 1523-0864, 01/2013, Volume 18, Issue 1, pp. 51 - 65
Aims: This study evaluates a possible relationship between reactive oxygen species (ROS) and cyclooxygenase (COX)-2-derived products in conductance and...
Original Research Communications | II-INFUSED MICE | RESPONSES | CELLS | OXIDATIVE STRESS | IMPAIRS ENDOTHELIAL FUNCTION | RESISTANCE ARTERIES | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENDOCRINOLOGY & METABOLISM | RATS | ANGIOTENSIN-II | HYDROGEN-PEROXIDE | NADPH OXIDASES | Reactive Oxygen Species - metabolism | Oxidative Stress | Rats, Inbred WKY | Endothelium, Vascular - drug effects | Male | Dinoprost - metabolism | Endothelium, Vascular - enzymology | Vasodilation | Phenylephrine - pharmacology | Cyclooxygenase 2 - genetics | Acetophenones - pharmacology | Aorta - physiopathology | Hypertension - enzymology | Aorta - enzymology | Pyrazoles - pharmacology | Rats, Inbred SHR | Vasoconstrictor Agents - pharmacology | Vasodilator Agents - pharmacology | Cyclooxygenase 2 Inhibitors - pharmacology | Mice, Inbred C57BL | Endothelium, Vascular - physiopathology | Rats | Cyclooxygenase 2 - physiology | Nitric Oxide - physiology | Antioxidants - pharmacology | Celecoxib | Sulfonamides - pharmacology | Hypertension - physiopathology | Animals | Cyclooxygenase 2 - metabolism | Mice | Cyclooxygenase 1 - metabolism | In Vitro Techniques | Nitric Oxide - metabolism | Hypertension | Cyclooxygenases | Development and progression | Reactive oxygen species | Research
Original Research Communications | II-INFUSED MICE | RESPONSES | CELLS | OXIDATIVE STRESS | IMPAIRS ENDOTHELIAL FUNCTION | RESISTANCE ARTERIES | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENDOCRINOLOGY & METABOLISM | RATS | ANGIOTENSIN-II | HYDROGEN-PEROXIDE | NADPH OXIDASES | Reactive Oxygen Species - metabolism | Oxidative Stress | Rats, Inbred WKY | Endothelium, Vascular - drug effects | Male | Dinoprost - metabolism | Endothelium, Vascular - enzymology | Vasodilation | Phenylephrine - pharmacology | Cyclooxygenase 2 - genetics | Acetophenones - pharmacology | Aorta - physiopathology | Hypertension - enzymology | Aorta - enzymology | Pyrazoles - pharmacology | Rats, Inbred SHR | Vasoconstrictor Agents - pharmacology | Vasodilator Agents - pharmacology | Cyclooxygenase 2 Inhibitors - pharmacology | Mice, Inbred C57BL | Endothelium, Vascular - physiopathology | Rats | Cyclooxygenase 2 - physiology | Nitric Oxide - physiology | Antioxidants - pharmacology | Celecoxib | Sulfonamides - pharmacology | Hypertension - physiopathology | Animals | Cyclooxygenase 2 - metabolism | Mice | Cyclooxygenase 1 - metabolism | In Vitro Techniques | Nitric Oxide - metabolism | Hypertension | Cyclooxygenases | Development and progression | Reactive oxygen species | Research
Journal Article
Prostaglandins and Other Lipid Mediators, ISSN 1098-8823, 01/2013, Volume 100-101, Issue 1, pp. 22 - 29
► Cytokines evoke colitis-like mucosal damage in human colonic explant tissue. ► Both exogenous and endogenous prostamides inhibit mucosal damage. ► The...
Prostamides | Colitis | Anandamide | Bimatoprost | COX-2 METABOLITE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENDOGENOUS CANNABINOID SYSTEM | RECEPTOR | CELL BIOLOGY | MATRIX METALLOPROTEINASES | INFLAMMATORY-BOWEL-DISEASE | UP-REGULATION | EXPRESSION | T-CELLS | Immunohistochemistry | Interleukin-1beta - pharmacology | Endocannabinoids - pharmacology | Humans | Middle Aged | Male | Receptors, Prostaglandin - metabolism | Colon, Sigmoid - metabolism | Young Adult | Cloprostenol - pharmacology | Adult | Female | Dinoprost - analogs & derivatives | Colon, Sigmoid - pathology | Dinoprost - pharmacology | Receptors, Prostaglandin - antagonists & inhibitors | Amides - pharmacology | Dinoprostone - pharmacology | Tissue Culture Techniques | Colon, Sigmoid - drug effects | Sulfonamides - pharmacology | Arachidonic Acids - pharmacology | Cloprostenol - analogs & derivatives | Cyclooxygenase Inhibitors - pharmacology | Tumor Necrosis Factor-alpha - pharmacology | Colitis - metabolism | Cyclooxygenase 2 - metabolism | Polyunsaturated Alkamides - pharmacology | Dinoprostone - analogs & derivatives | Oxazoles - pharmacology | Colitis - prevention & control | Metabolites | Prostaglandins
Prostamides | Colitis | Anandamide | Bimatoprost | COX-2 METABOLITE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENDOGENOUS CANNABINOID SYSTEM | RECEPTOR | CELL BIOLOGY | MATRIX METALLOPROTEINASES | INFLAMMATORY-BOWEL-DISEASE | UP-REGULATION | EXPRESSION | T-CELLS | Immunohistochemistry | Interleukin-1beta - pharmacology | Endocannabinoids - pharmacology | Humans | Middle Aged | Male | Receptors, Prostaglandin - metabolism | Colon, Sigmoid - metabolism | Young Adult | Cloprostenol - pharmacology | Adult | Female | Dinoprost - analogs & derivatives | Colon, Sigmoid - pathology | Dinoprost - pharmacology | Receptors, Prostaglandin - antagonists & inhibitors | Amides - pharmacology | Dinoprostone - pharmacology | Tissue Culture Techniques | Colon, Sigmoid - drug effects | Sulfonamides - pharmacology | Arachidonic Acids - pharmacology | Cloprostenol - analogs & derivatives | Cyclooxygenase Inhibitors - pharmacology | Tumor Necrosis Factor-alpha - pharmacology | Colitis - metabolism | Cyclooxygenase 2 - metabolism | Polyunsaturated Alkamides - pharmacology | Dinoprostone - analogs & derivatives | Oxazoles - pharmacology | Colitis - prevention & control | Metabolites | Prostaglandins
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 05/2001, Volume 133, Issue 1, pp. 117 - 124
The effects of an oral daily dose (10 mg kg−1) of the flavonoid quercetin for 5 weeks in spontaneously hypertensive (SHR) and normotensive Wistar Kyoto rats...
antioxidant | flavonoid | SHR | hypertension | Quercetin | Hypertension | Antioxidant | Flavonoid | OXIDATIVE STRESS | BIOCHEMISTRY & MOLECULAR BIOLOGY | RISK | CORONARY HEART-DISEASE | VASCULAR SMOOTH-MUSCLE | BLOOD-PRESSURE | PLASMA | ANTIOXIDANT STATUS | IN-VIVO | NITRIC-OXIDE | CARDIOVASCULAR-DISEASE | quercetin | PHARMACOLOGY & PHARMACY | Norepinephrine - pharmacology | Kidney - pathology | Body Weight - drug effects | Rats, Inbred WKY | Endothelium, Vascular - drug effects | Hypertension - drug therapy | Male | Nitroprusside - pharmacology | Endothelium, Vascular - physiology | Heart Rate - drug effects | Malondialdehyde - blood | Potassium Chloride - pharmacology | Quercetin - administration & dosage | Blood Pressure - drug effects | Dinoprost - analogs & derivatives | Oxidants - blood | Oxidants - urine | Heart Ventricles - pathology | Rats, Inbred SHR | Vasoconstrictor Agents - pharmacology | Kidney - drug effects | Vasodilator Agents - pharmacology | Dinoprost - urine | Acetylcholine - pharmacology | Quercetin - therapeutic use | Aorta - drug effects | Rats | Antioxidants - pharmacology | Antioxidants - therapeutic use | Organ Size - drug effects | Animals | Quercetin - pharmacology | Antioxidants - administration & dosage | Aorta - cytology | Vasodilation - drug effects | In Vitro Techniques | Aorta - physiology | Heart Ventricles - drug effects | Papers
antioxidant | flavonoid | SHR | hypertension | Quercetin | Hypertension | Antioxidant | Flavonoid | OXIDATIVE STRESS | BIOCHEMISTRY & MOLECULAR BIOLOGY | RISK | CORONARY HEART-DISEASE | VASCULAR SMOOTH-MUSCLE | BLOOD-PRESSURE | PLASMA | ANTIOXIDANT STATUS | IN-VIVO | NITRIC-OXIDE | CARDIOVASCULAR-DISEASE | quercetin | PHARMACOLOGY & PHARMACY | Norepinephrine - pharmacology | Kidney - pathology | Body Weight - drug effects | Rats, Inbred WKY | Endothelium, Vascular - drug effects | Hypertension - drug therapy | Male | Nitroprusside - pharmacology | Endothelium, Vascular - physiology | Heart Rate - drug effects | Malondialdehyde - blood | Potassium Chloride - pharmacology | Quercetin - administration & dosage | Blood Pressure - drug effects | Dinoprost - analogs & derivatives | Oxidants - blood | Oxidants - urine | Heart Ventricles - pathology | Rats, Inbred SHR | Vasoconstrictor Agents - pharmacology | Kidney - drug effects | Vasodilator Agents - pharmacology | Dinoprost - urine | Acetylcholine - pharmacology | Quercetin - therapeutic use | Aorta - drug effects | Rats | Antioxidants - pharmacology | Antioxidants - therapeutic use | Organ Size - drug effects | Animals | Quercetin - pharmacology | Antioxidants - administration & dosage | Aorta - cytology | Vasodilation - drug effects | In Vitro Techniques | Aorta - physiology | Heart Ventricles - drug effects | Papers
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 08/2013, Volume 305, Issue 3, pp. H344 - H353
A contributing factor to increased peripheral resistance seen during hypertension is an increased production of endothelium-derived contractile factors...
Cyclooxygenase | EDCF | ERK1/2 | cPLA | Endoplasmic reticulum stress | CYTOSOLIC PHOSPHOLIPASE A | OXIDATIVE STRESS | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | MESENTERIC-ARTERIES | ER STRESS | OLETF RATS | cyclooxygenase | endoplasmic reticulum stress | PROSTANOID RECEPTORS | UNFOLDED PROTEIN RESPONSE | GENE-EXPRESSION | RENAL-ARTERIES | PERIPHERAL VASCULAR DISEASE | SMOOTH-MUSCLE-CELLS | Antihypertensive Agents - pharmacology | Epoprostenol - metabolism | Phosphorylation | Muscle, Smooth, Vascular - metabolism | Rats, Inbred WKY | Endothelium, Vascular - drug effects | Hypertension - drug therapy | Male | Aorta - metabolism | Dinoprost - metabolism | Muscle, Smooth, Vascular - physiopathology | Dose-Response Relationship, Drug | Taurochenodeoxycholic Acid - pharmacology | Phenylbutyrates - pharmacology | tert-Butylhydroperoxide - pharmacology | Blood Pressure - drug effects | Membrane Proteins - metabolism | Aorta - physiopathology | Myocytes, Smooth Muscle - drug effects | Myocytes, Smooth Muscle - metabolism | Disease Models, Animal | Muscle, Smooth, Vascular - drug effects | Rats, Inbred SHR | Vasoconstrictor Agents - pharmacology | Vasodilator Agents - pharmacology | Endoplasmic Reticulum Stress - drug effects | Acetylcholine - pharmacology | Aorta - drug effects | Cells, Cultured | Endothelium, Vascular - physiopathology | bcl-2-Associated X Protein - metabolism | Rats | Vasoconstriction - drug effects | Hypertension - physiopathology | Phospholipases A2, Cytosolic - metabolism | Hydrogen Peroxide - metabolism | Hypertension - metabolism | Thromboxane A2 - metabolism | Animals | Mitogen-Activated Protein Kinase 3 - metabolism | Signal Transduction - drug effects | Endothelium, Vascular - metabolism | Arachidonic Acid - pharmacology | Cyclooxygenase 1 - metabolism | Mitogen-Activated Protein Kinase 1 - metabolism | Hypertension | Physiological aspects | Stress (Physiology) | Endoplasmic reticulum | Health aspects | Muscle contraction | cPLA2 | Vascular Biology and Microcirculation | ERK1
Cyclooxygenase | EDCF | ERK1/2 | cPLA | Endoplasmic reticulum stress | CYTOSOLIC PHOSPHOLIPASE A | OXIDATIVE STRESS | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | MESENTERIC-ARTERIES | ER STRESS | OLETF RATS | cyclooxygenase | endoplasmic reticulum stress | PROSTANOID RECEPTORS | UNFOLDED PROTEIN RESPONSE | GENE-EXPRESSION | RENAL-ARTERIES | PERIPHERAL VASCULAR DISEASE | SMOOTH-MUSCLE-CELLS | Antihypertensive Agents - pharmacology | Epoprostenol - metabolism | Phosphorylation | Muscle, Smooth, Vascular - metabolism | Rats, Inbred WKY | Endothelium, Vascular - drug effects | Hypertension - drug therapy | Male | Aorta - metabolism | Dinoprost - metabolism | Muscle, Smooth, Vascular - physiopathology | Dose-Response Relationship, Drug | Taurochenodeoxycholic Acid - pharmacology | Phenylbutyrates - pharmacology | tert-Butylhydroperoxide - pharmacology | Blood Pressure - drug effects | Membrane Proteins - metabolism | Aorta - physiopathology | Myocytes, Smooth Muscle - drug effects | Myocytes, Smooth Muscle - metabolism | Disease Models, Animal | Muscle, Smooth, Vascular - drug effects | Rats, Inbred SHR | Vasoconstrictor Agents - pharmacology | Vasodilator Agents - pharmacology | Endoplasmic Reticulum Stress - drug effects | Acetylcholine - pharmacology | Aorta - drug effects | Cells, Cultured | Endothelium, Vascular - physiopathology | bcl-2-Associated X Protein - metabolism | Rats | Vasoconstriction - drug effects | Hypertension - physiopathology | Phospholipases A2, Cytosolic - metabolism | Hydrogen Peroxide - metabolism | Hypertension - metabolism | Thromboxane A2 - metabolism | Animals | Mitogen-Activated Protein Kinase 3 - metabolism | Signal Transduction - drug effects | Endothelium, Vascular - metabolism | Arachidonic Acid - pharmacology | Cyclooxygenase 1 - metabolism | Mitogen-Activated Protein Kinase 1 - metabolism | Hypertension | Physiological aspects | Stress (Physiology) | Endoplasmic reticulum | Health aspects | Muscle contraction | cPLA2 | Vascular Biology and Microcirculation | ERK1
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 2003, Volume 465, Issue 1, pp. 1 - 7
Cephalosporin antibiotics are thought to be excreted into the urine via organic anion transporters (OATs) and OAT can mediate nephrotoxicity by cephalosporins,...
Proximal tubule | Cell line | Transport | Cephalosporin antibiotic | Organic anion transporter | cephalosporin antibiotic | organic anion transporter | transport | MEDIATE | IDENTIFICATION | CATION TRANSPORTERS | BETA-LACTAM ANTIBIOTICS | PHARMACOLOGY & PHARMACY | MOLECULAR-CLONING | INHIBITORS | proximal tubule | KIDNEY | cell line | EXPRESSION | CEPHALORIDINE | NEPHROTOXICITY | Cefoperazone - pharmacology | Organic Anion Transporters, Sodium-Independent - genetics | Humans | Ceftriaxone - pharmacology | Dose-Response Relationship, Drug | Cefamandole - pharmacology | Transfection | Organic Anion Transporters, Sodium-Independent - metabolism | Cefadroxil - pharmacology | Biological Transport - drug effects | Cephalosporins - pharmacology | Cell Line | Cell Survival - drug effects | Cefazolin - pharmacology | Dinoprost - pharmacokinetics | Cephalothin - pharmacology | Probenecid - pharmacology | Rats | Mice, Transgenic | Cephaloridine - pharmacology | Animals | Uricosuric Agents - pharmacology | Cefotaxime - pharmacology | Anti-Bacterial Agents - pharmacology | Mice | Kinetics
Proximal tubule | Cell line | Transport | Cephalosporin antibiotic | Organic anion transporter | cephalosporin antibiotic | organic anion transporter | transport | MEDIATE | IDENTIFICATION | CATION TRANSPORTERS | BETA-LACTAM ANTIBIOTICS | PHARMACOLOGY & PHARMACY | MOLECULAR-CLONING | INHIBITORS | proximal tubule | KIDNEY | cell line | EXPRESSION | CEPHALORIDINE | NEPHROTOXICITY | Cefoperazone - pharmacology | Organic Anion Transporters, Sodium-Independent - genetics | Humans | Ceftriaxone - pharmacology | Dose-Response Relationship, Drug | Cefamandole - pharmacology | Transfection | Organic Anion Transporters, Sodium-Independent - metabolism | Cefadroxil - pharmacology | Biological Transport - drug effects | Cephalosporins - pharmacology | Cell Line | Cell Survival - drug effects | Cefazolin - pharmacology | Dinoprost - pharmacokinetics | Cephalothin - pharmacology | Probenecid - pharmacology | Rats | Mice, Transgenic | Cephaloridine - pharmacology | Animals | Uricosuric Agents - pharmacology | Cefotaxime - pharmacology | Anti-Bacterial Agents - pharmacology | Mice | Kinetics
Journal Article
Molecular and Cellular Endocrinology, ISSN 0303-7207, 03/2015, Volume 403, pp. 46 - 56
Activation of G protein-coupled receptors (GPCRs) can induce vasoconstriction via calcium signal-mediated and Rho-dependent pathways. Earlier reports have...
G protein-coupled receptor | Calcium signaling | Blood pressure | Endocannabinoid | Angiotensin II | Vasoconstriction | Lipoprotein Lipase - antagonists & inhibitors | Endocannabinoids - pharmacology | Muscle, Smooth, Vascular - metabolism | Rats, Wistar | Calcium - metabolism | Monoacylglycerol Lipases - antagonists & inhibitors | GTP-Binding Protein alpha Subunits, Gq-G11 - deficiency | Hypertension - drug therapy | Male | Lactones - pharmacology | Monoacylglycerol Lipases - genetics | Monoacylglycerol Lipases - metabolism | Phenylephrine - pharmacology | Piperidines - pharmacology | Hypertension - genetics | Myocytes, Smooth Muscle - drug effects | Dinoprost - pharmacology | Lipoprotein Lipase - metabolism | Myocytes, Smooth Muscle - cytology | Myocytes, Smooth Muscle - metabolism | Calcium Signaling | Muscle, Smooth, Vascular - drug effects | GTP-Binding Protein alpha Subunits, Gq-G11 - genetics | Angiotensin II - pharmacology | Lipoprotein Lipase - genetics | Tissue Culture Techniques | Aorta - drug effects | Gene Expression Regulation | Rats | Muscle, Smooth, Vascular - cytology | Vasoconstriction - drug effects | Arachidonic Acids - pharmacology | Hypertension - physiopathology | Hypertension - metabolism | Mice, Knockout | Receptor, Cannabinoid, CB1 - metabolism | Glycerides - pharmacology | Animals | Receptor, Cannabinoid, CB1 - genetics | Mice | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Benzodioxoles - pharmacology
G protein-coupled receptor | Calcium signaling | Blood pressure | Endocannabinoid | Angiotensin II | Vasoconstriction | Lipoprotein Lipase - antagonists & inhibitors | Endocannabinoids - pharmacology | Muscle, Smooth, Vascular - metabolism | Rats, Wistar | Calcium - metabolism | Monoacylglycerol Lipases - antagonists & inhibitors | GTP-Binding Protein alpha Subunits, Gq-G11 - deficiency | Hypertension - drug therapy | Male | Lactones - pharmacology | Monoacylglycerol Lipases - genetics | Monoacylglycerol Lipases - metabolism | Phenylephrine - pharmacology | Piperidines - pharmacology | Hypertension - genetics | Myocytes, Smooth Muscle - drug effects | Dinoprost - pharmacology | Lipoprotein Lipase - metabolism | Myocytes, Smooth Muscle - cytology | Myocytes, Smooth Muscle - metabolism | Calcium Signaling | Muscle, Smooth, Vascular - drug effects | GTP-Binding Protein alpha Subunits, Gq-G11 - genetics | Angiotensin II - pharmacology | Lipoprotein Lipase - genetics | Tissue Culture Techniques | Aorta - drug effects | Gene Expression Regulation | Rats | Muscle, Smooth, Vascular - cytology | Vasoconstriction - drug effects | Arachidonic Acids - pharmacology | Hypertension - physiopathology | Hypertension - metabolism | Mice, Knockout | Receptor, Cannabinoid, CB1 - metabolism | Glycerides - pharmacology | Animals | Receptor, Cannabinoid, CB1 - genetics | Mice | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Benzodioxoles - pharmacology
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 05/2015, Volume 67, Issue 5, pp. 714 - 719
Objectives The aim of this study was to investigate the cardiovascular relaxing properties of monoterpene alcohol (‐)‐linalool (LIN), a principal component of...
K+ channel | (‐)‐linalool | soluble guanylyl cyclase | vasorelaxation | channel | (-)-linalool | Vasorelaxation | Soluble guanylyl cyclase | K + channel | SMOOTH-MUSCLE | POTASSIUM CHANNELS | ESSENTIAL OIL | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | STRESS | HYPERTENSIVE-RATS | BLOOD-PRESSURE | NG-Nitroarginine Methyl Ester - pharmacology | Tetraethylammonium - pharmacology | Vasodilator Agents - pharmacology | Calcium - metabolism | Aorta - drug effects | Endoplasmic Reticulum - metabolism | Guanylate Cyclase - metabolism | Male | Aorta - metabolism | Enzyme Activation - drug effects | Dose-Response Relationship, Drug | Potassium Channels - metabolism | Quinoxalines - pharmacology | Calcium Chloride - pharmacology | Monoterpenes - pharmacology | Animals | Oxadiazoles - pharmacology | Calcium Chloride - antagonists & inhibitors | Dinoprost - antagonists & inhibitors | Mice | Monoterpenes - antagonists & inhibitors | Vasodilation - drug effects | Dinoprost - pharmacology | Blood vessels | Dilatation | Nitric oxide
K+ channel | (‐)‐linalool | soluble guanylyl cyclase | vasorelaxation | channel | (-)-linalool | Vasorelaxation | Soluble guanylyl cyclase | K + channel | SMOOTH-MUSCLE | POTASSIUM CHANNELS | ESSENTIAL OIL | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | STRESS | HYPERTENSIVE-RATS | BLOOD-PRESSURE | NG-Nitroarginine Methyl Ester - pharmacology | Tetraethylammonium - pharmacology | Vasodilator Agents - pharmacology | Calcium - metabolism | Aorta - drug effects | Endoplasmic Reticulum - metabolism | Guanylate Cyclase - metabolism | Male | Aorta - metabolism | Enzyme Activation - drug effects | Dose-Response Relationship, Drug | Potassium Channels - metabolism | Quinoxalines - pharmacology | Calcium Chloride - pharmacology | Monoterpenes - pharmacology | Animals | Oxadiazoles - pharmacology | Calcium Chloride - antagonists & inhibitors | Dinoprost - antagonists & inhibitors | Mice | Monoterpenes - antagonists & inhibitors | Vasodilation - drug effects | Dinoprost - pharmacology | Blood vessels | Dilatation | Nitric oxide
Journal Article
Peptides, ISSN 0196-9781, 12/2015, Volume 74, pp. 64 - 69
Urocortin 1 (Ucn1) is a 40-amino-acid peptide that has vasodilatory activity and displays immunomodulatory and antioxidant properties. Maternal and cord plasma...
Urocortin | Dexamethasone | Interferon-γ | Endothelin-1 | HUVEC | Interleukin-8 | LPS | Interferon-gamma | ENDOMETRIUM | BIOCHEMISTRY & MOLECULAR BIOLOGY | INNERVATION | HUMAN PLACENTAL CELLS | BLOOD-FLOW | PEPTIDE | ACTIVIN-A | CORTICOTROPIN-RELEASING-FACTOR | HORMONE | MESSENGER-RNA | PHARMACOLOGY & PHARMACY | INFLAMMATORY CYTOKINES | Gene Expression | Human Umbilical Vein Endothelial Cells - drug effects | Human Umbilical Vein Endothelial Cells - metabolism | Endothelin-1 - pharmacology | Humans | Cells, Cultured | Urocortins - genetics | Pregnancy | Urocortins - metabolism | Dexamethasone - pharmacology | Lipopolysaccharides - pharmacology | Female | Interleukin-8 - pharmacology | Dinoprost - pharmacology | Progesterone - pharmacology | Estradiol - pharmacology | Interferon-gamma - pharmacology
Urocortin | Dexamethasone | Interferon-γ | Endothelin-1 | HUVEC | Interleukin-8 | LPS | Interferon-gamma | ENDOMETRIUM | BIOCHEMISTRY & MOLECULAR BIOLOGY | INNERVATION | HUMAN PLACENTAL CELLS | BLOOD-FLOW | PEPTIDE | ACTIVIN-A | CORTICOTROPIN-RELEASING-FACTOR | HORMONE | MESSENGER-RNA | PHARMACOLOGY & PHARMACY | INFLAMMATORY CYTOKINES | Gene Expression | Human Umbilical Vein Endothelial Cells - drug effects | Human Umbilical Vein Endothelial Cells - metabolism | Endothelin-1 - pharmacology | Humans | Cells, Cultured | Urocortins - genetics | Pregnancy | Urocortins - metabolism | Dexamethasone - pharmacology | Lipopolysaccharides - pharmacology | Female | Interleukin-8 - pharmacology | Dinoprost - pharmacology | Progesterone - pharmacology | Estradiol - pharmacology | Interferon-gamma - pharmacology
Journal Article
Vascular Pharmacology, ISSN 1537-1891, 2006, Volume 46, Issue 3, pp. 215 - 222
Abstract We studied the mechanisms involved in the relaxation induced by nitric oxide (NO) donors, ruthenium complex ([Ru(terpy)(bdq)NO+ ]3+ -TERPY) and sodium...
Cardiovascular | Nitric oxide species | Nitric oxide donor | K + channels and vasorelaxation | Guanylyl cyclase | channels and vasorelaxation | ACTIVATION | nitric oxide species | ENDOTHELIAL DYSFUNCTION | POTASSIUM CHANNELS | MESENTERIC-ARTERY | PULMONARY-ARTERY | SOLUBLE GUANYLATE-CYCLASE | GLYCERYL TRINITRATE | VASCULAR SMOOTH-MUSCLE | guanylyl cyclase | K+ channels and vasorelaxation | PHARMACOLOGY & PHARMACY | nitric oxide donor | RAT AORTIC RINGS | VISIBLE-LIGHT IRRADIATION | Free Radical Scavengers - pharmacology | Norepinephrine - pharmacology | Oxyhemoglobins - metabolism | Vasodilator Agents - pharmacology | Rats, Wistar | Enzyme Inhibitors - pharmacology | Rats | Endothelium, Vascular - drug effects | Male | Guanylate Cyclase - antagonists & inhibitors | Nitroprusside - pharmacology | Animals | Phenylephrine - pharmacology | Cyclic GMP - metabolism | Cysteine - pharmacology | Sarcoplasmic Reticulum Calcium-Transporting ATPases - antagonists & inhibitors | Aorta, Thoracic - drug effects | Nitric Oxide Donors - pharmacology | Vasodilation - drug effects | In Vitro Techniques | Dinoprost - pharmacology | Potassium Channel Blockers - pharmacology | Ruthenium Compounds - pharmacology | Sodium nitroferricyanide | Ruthenium | Comparative analysis | Nitric oxide
Cardiovascular | Nitric oxide species | Nitric oxide donor | K + channels and vasorelaxation | Guanylyl cyclase | channels and vasorelaxation | ACTIVATION | nitric oxide species | ENDOTHELIAL DYSFUNCTION | POTASSIUM CHANNELS | MESENTERIC-ARTERY | PULMONARY-ARTERY | SOLUBLE GUANYLATE-CYCLASE | GLYCERYL TRINITRATE | VASCULAR SMOOTH-MUSCLE | guanylyl cyclase | K+ channels and vasorelaxation | PHARMACOLOGY & PHARMACY | nitric oxide donor | RAT AORTIC RINGS | VISIBLE-LIGHT IRRADIATION | Free Radical Scavengers - pharmacology | Norepinephrine - pharmacology | Oxyhemoglobins - metabolism | Vasodilator Agents - pharmacology | Rats, Wistar | Enzyme Inhibitors - pharmacology | Rats | Endothelium, Vascular - drug effects | Male | Guanylate Cyclase - antagonists & inhibitors | Nitroprusside - pharmacology | Animals | Phenylephrine - pharmacology | Cyclic GMP - metabolism | Cysteine - pharmacology | Sarcoplasmic Reticulum Calcium-Transporting ATPases - antagonists & inhibitors | Aorta, Thoracic - drug effects | Nitric Oxide Donors - pharmacology | Vasodilation - drug effects | In Vitro Techniques | Dinoprost - pharmacology | Potassium Channel Blockers - pharmacology | Ruthenium Compounds - pharmacology | Sodium nitroferricyanide | Ruthenium | Comparative analysis | Nitric oxide
Journal Article
EUROPEAN JOURNAL OF PHARMACOLOGY, ISSN 0014-2999, 01/2014, Volume 723, pp. 216 - 226
Hypoxia-induced coronary vasorelaxation is a compensatory mechanism increasing blood flow. We hypothesized that hypoxia shares pathways with adenosine and...
Force suppression | MLC | PROTEIN-KINASE | SWINE | MYOCARDIAL-ISCHEMIA | RELAXATION | Vasorelaxation | DILATION | VASCULAR SMOOTH-MUSCLE | HSP20 PHOSPHORYLATION | INHIBITION | NITRIC-OXIDE | Hypoxia | Coronary | PHARMACOLOGY & PHARMACY | HSP20 | CAMP | K+ CHANNELS | Coronary Vessels - drug effects | Triazines - pharmacology | Phenethylamines - pharmacology | Oxygen - physiology | Coronary Vessels - physiology | Adenosine-5'-(N-ethylcarboxamide) - pharmacology | Purinergic P1 Receptor Agonists - pharmacology | Receptors, Purinergic P1 - physiology | Adenosine - pharmacology | HSP20 Heat-Shock Proteins - metabolism | Purinergic P1 Receptor Antagonists - pharmacology | Triazoles - pharmacology | Animals | Swine | Adenosine - analogs & derivatives | Hypoxia - physiopathology | Vasodilation - drug effects | Vasodilation - physiology | In Vitro Techniques | Cyclic AMP - metabolism | Dinoprost - pharmacology | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Farmakologi och toxikologi | Pharmacology and Toxicology
Force suppression | MLC | PROTEIN-KINASE | SWINE | MYOCARDIAL-ISCHEMIA | RELAXATION | Vasorelaxation | DILATION | VASCULAR SMOOTH-MUSCLE | HSP20 PHOSPHORYLATION | INHIBITION | NITRIC-OXIDE | Hypoxia | Coronary | PHARMACOLOGY & PHARMACY | HSP20 | CAMP | K+ CHANNELS | Coronary Vessels - drug effects | Triazines - pharmacology | Phenethylamines - pharmacology | Oxygen - physiology | Coronary Vessels - physiology | Adenosine-5'-(N-ethylcarboxamide) - pharmacology | Purinergic P1 Receptor Agonists - pharmacology | Receptors, Purinergic P1 - physiology | Adenosine - pharmacology | HSP20 Heat-Shock Proteins - metabolism | Purinergic P1 Receptor Antagonists - pharmacology | Triazoles - pharmacology | Animals | Swine | Adenosine - analogs & derivatives | Hypoxia - physiopathology | Vasodilation - drug effects | Vasodilation - physiology | In Vitro Techniques | Cyclic AMP - metabolism | Dinoprost - pharmacology | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Farmakologi och toxikologi | Pharmacology and Toxicology
Journal Article